CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −29,350 | $75.86 | $2.2M | 4,485.82 |
| 2023-09-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 234,800 | ||
| 2023-08-31 | MUSSALLEM MICHAEL A Director | Gift | −49,766 | 4,485.82 | ||
| 2023-08-31 | MUSSALLEM MICHAEL A Director | Gift | +49,766 | 3,666,688 | ||
| 2023-08-31 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +7,255 | $36.75 | $267K | 26,503 |
| 2023-08-31 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,255 | $77.79 | $564K | 19,248 |
| 2023-08-31 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −7,255 | 58,035 | ||
| 2023-08-29 | Chopra Daveen CVP, TMTT | Sale | −1,500 | $76.69 | $115K | 23,950 |
| 2023-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +4,500 | $36.75 | $165K | 44,002.69 |
| 2023-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −4,500 | $79.30 | $357K | 39,502.69 |
| 2023-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −4,500 | 71,500 | ||
| 2023-08-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion 10b5-1 | +6,421 | $45.28 | $291K | 220,214.71 |
| 2023-08-14 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −6,421 | $79.30 | $509K | 213,793.71 |
| 2023-08-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −6,421 | 34,638 | ||
| 2023-08-10 | STONE HEISZ LESLIE Director | Sale | −3,303 | $78.87 | $261K | 26,980 |
| 2023-08-09 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion 10b5-1 | +5,000 | $36.75 | $184K | 39,813.57 |
| 2023-08-09 | Szyman Catherine M. CVP, Critical Care | Sale 10b5-1 | −5,000 | $78.64 | $393K | 34,813.57 |
| 2023-08-09 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 57,000 | ||
| 2023-08-07 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 83,601.82 |
| 2023-08-07 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −300 | $80.54 | $24K | 83,301.82 |
Page 35 of 43 · 841 trades